Bank Of New York Mellon Corp Cytosorbents Corp Transaction History

Bank Of New York Mellon Corp

$528 Trillion
Q2 2024

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 09, 2023	BUY	$1.79 - $4.17 $94,209 - $219,471	52,631 New	52,631 $177 Million
Q4 2022 Feb 14, 2023	BUY	$1.03 - $2.03 $54,834 - $108,071	53,237 New	53,237 $82,000
Q2 2022 Aug 15, 2022	SELL	$1.76 - $3.22 $186,941 - $342,018	-106,217 Reduced 66.51%	53,473 $117,000
Q4 2021 Feb 11, 2022	SELL	$4.05 - $8.11 $28,568 - $57,207	-7,054 Reduced 4.23%	159,690 $669,000
Q3 2021 Nov 12, 2021	BUY	$7.0 - $9.71 $77,735 - $107,829	11,105 Added 7.14%	166,744 $1.35 Million
Q2 2021 Aug 11, 2021	SELL	$7.55 - $9.42 $45,466 - $56,727	-6,022 Reduced 3.73%	155,639 $1.18 Million
Q1 2021 May 13, 2021	SELL	$8.23 - $11.48 $313,192 - $436,871	-38,055 Reduced 19.05%	161,661 $1.4 Million
Q4 2020 Feb 09, 2021	BUY	$7.65 - $8.98 $152,747 - $179,303	19,967 Added 11.11%	199,716 $1.59 Million
Q3 2020 Nov 12, 2020	BUY	$7.37 - $11.54 $176,798 - $276,833	23,989 Added 15.4%	179,749 $1.43 Million
Q2 2020 Aug 12, 2020	SELL	$6.28 - $10.59 $20,183 - $34,036	-3,214 Reduced 2.02%	155,760 $1.54 Million
Q1 2020 May 06, 2020	BUY	$3.77 - $7.73 $144,364 - $296,004	38,293 Added 31.73%	158,974 $1.23 Million
Q4 2019 Feb 14, 2020	BUY	$3.61 - $5.22 $23,609 - $34,138	6,540 Added 5.73%	120,681 $464,000
Q3 2019 Nov 07, 2019	BUY	$4.33 - $7.63 $61,252 - $107,933	14,146 Added 14.15%	114,141 $574,000
Q2 2019 Aug 12, 2019	SELL	$5.92 - $7.78 $4,096 - $5,383	-692 Reduced 0.69%	99,995 $661,000
Q1 2019 May 14, 2019	BUY	$6.82 - $8.56 $22,894 - $28,735	3,357 Added 3.45%	100,687 $762,000
Q4 2018 Feb 11, 2019	BUY	$7.05 - $12.64 $17,737 - $31,802	2,516 Added 2.65%	97,330 $786,000
Q3 2018 Nov 09, 2018	BUY	$10.95 - $14.8 $127,742 - $172,656	11,666 Added 14.03%	94,814 $0
Q2 2018 Aug 06, 2018	BUY	$6.9 - $12.35 $370,129 - $662,478	53,642 Added 181.8%	83,148 $948,000
Q1 2018 May 15, 2018	BUY	$6.55 - $8.2 $28,237 - $35,350	4,311 Added 17.11%	29,506 $208,000
Q4 2017 Feb 09, 2018	BUY	$5.9 - $7.05 $148,650 - $177,624	25,195	25,195 $164,000

Others Institutions Holding CTSO

# of Institutions

Shares Held

16.9M

Call Options Held

10.1K

Put Options Held

500

Avenir Corp Washington, DC

2.97M
Shares

$3.53 Million
0.21% of portfolio
Skylands Capital, LLC

2.84M
Shares

$3.38 Million
0.3% of portfolio
Granahan Investment Management, LLC Waltham, MA

2.66M
Shares

$3.17 Million
0.08% of portfolio
Vanguard Group Inc Valley Forge, PA

1.95M
Shares

$2.32 Million
0.0% of portfolio
Neuberger Berman Group LLC New York, NY

1.54M
Shares

$1.83 Million
0.0% of portfolio

View Full List

About Cytosorbents Corp

Ticker CTSO
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 43,577,400
Market Cap $51.9M
Description
Cytosorbents Corporation engages in the research, development, and commercialization of medical devices with its blood purification technology platform incorporating a proprietary adsorbent and porous polymer technology. Its flagship product is CytoSorb, an extracorporeal cytokine filter for adjunctive therapy in the treatment of sepsis, adjunct...

More about CTSO

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Bank Of New York Mellon Corp, based on Form 13F filings with the SEC.

News

Stay updated on Bank Of New York Mellon Corp with notifications on news.

Account